Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Clopidogrel in Large Vessel Ischemic Stroke
NCT06120725Phase 3Completed
- Sponsor
- Kafrelsheikh University
- Start
- Sep 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in ischemic stroke, sponsored by Kafrelsheikh University. Started Sep 2021; status: completed.
02
Drugs
ticagrelor
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06120725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06120725.